| Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange M Van Der Neut Kolfschoten, J Schuurman, M Losen, WK Bleeker, ... Science 317 (5844), 1554-1557, 2007 | 1145 | 2007 |
| A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis P Zisimopoulou, P Evangelakou, J Tzartos, K Lazaridis, V Zouvelou, ... Journal of autoimmunity 52, 139-145, 2014 | 332 | 2014 |
| MuSK IgG4 autoantibodies cause myasthenia gravis by inhibiting binding between MuSK and Lrp4 MG Huijbers, W Zhang, R Klooster, EH Niks, MB Friese, KR Straasheijm, ... Proceedings of the National Academy of Sciences 110 (51), 20783-20788, 2013 | 296 | 2013 |
| Effect of Oxygen Limitation and Medium Composition on Escherichia coli Fermentation in Shake‐Flask Cultures M Losen, B Frölich, M Pohl, J Büchs Biotechnology progress 20 (4), 1062-1068, 2004 | 243 | 2004 |
| Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice R Klooster, JJ Plomp, MG Huijbers, EH Niks, KR Straasheijm, FJ Detmers, ... Brain 135 (4), 1081-1101, 2012 | 239 | 2012 |
| The features of myasthenia gravis with autoantibodies to MuSK D Lavrnic, M Losen, A Vujic, M De Baets, LJ Hajdukovic, V Stojanovic, ... Journal of Neurology, Neurosurgery & Psychiatry 76 (8), 1099-1102, 2005 | 210 | 2005 |
| Advances in understanding and modeling the gas–liquid mass transfer in shake flasks U Maier, M Losen, J Büchs Biochemical Engineering Journal 17 (3), 155-167, 2004 | 200 | 2004 |
| Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4 JJGM Verschuuren, MG Huijbers, JJ Plomp, EH Niks, PC Molenaar, ... Autoimmunity reviews 12 (9), 918-923, 2013 | 199 | 2013 |
| The lipid droplet coat protein perilipin 5 also localizes to muscle mitochondria M Bosma, R Minnaard, LM Sparks, G Schaart, M Losen, MH De Baets, ... Histochemistry and cell biology 137, 205-216, 2012 | 198 | 2012 |
| Antibody effector mechanisms in myasthenia gravis—pathogenesis at the neuromuscular junction AM Gomez, J Van Den Broeck, K Vrolix, SP Janssen, MAM Lemmens, ... Autoimmunity 43 (5-6), 353-370, 2010 | 157 | 2010 |
| Proteasome inhibition with bortezomib depletes plasma cells and autoantibodies in experimental autoimmune myasthenia gravis AM Gomez, K Vrolix, P Martínez-Martínez, PC Molenaar, M Phernambucq, ... The Journal of Immunology 186 (4), 2503-2513, 2011 | 146 | 2011 |
| IgG4 autoantibodies against muscle-specific kinase undergo Fab-arm exchange in myasthenia gravis patients I Koneczny, JAA Stevens, A De Rosa, S Huda, MG Huijbers, A Saxena, ... Journal of autoimmunity 77, 104-115, 2017 | 125 | 2017 |
| Main immunogenic region structure promotes binding of conformation-dependent myasthenia gravis autoantibodies, nicotinic acetylcholine receptor conformation maturation, and … J Luo, P Taylor, M Losen, MH de Baets, GD Shelton, J Lindstrom Journal of Neuroscience 29 (44), 13898-13908, 2009 | 102 | 2009 |
| Muscle disuse atrophy is not accompanied by changes in skeletal muscle satellite cell content T Snijders, BT Wall, ML Dirks, JMG Senden, F Hartgens, J Dolmans, ... Clinical science 126 (8), 557-566, 2014 | 97 | 2014 |
| Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis M Losen, MHW Stassen, P Martínez-Martínez, BM Machiels, H Duimel, ... Brain 128 (10), 2327-2337, 2005 | 92 | 2005 |
| In vivo electroporation of the central nervous system: a non-viral approach for targeted gene delivery J De Vry, P Martínez-Martínez, M Losen, Y Temel, T Steckler, ... Progress in neurobiology 92 (3), 227-244, 2010 | 91 | 2010 |
| MuSK autoantibodies in myasthenia gravis detected by cell based assay—a multinational study AI Tsonis, P Zisimopoulou, K Lazaridis, J Tzartos, E Matsigkou, ... Journal of neuroimmunology 284, 10-17, 2015 | 86 | 2015 |
| IL‐17‐producing CD4+ T cells contribute to the loss of B‐cell tolerance in experimental autoimmune myasthenia gravis H Schaffert, A Pelz, A Saxena, M Losen, A Meisel, A Thiel, S Kohler European journal of immunology 45 (5), 1339-1347, 2015 | 83 | 2015 |
| Sphingolipids in Alzheimer's disease, how can we target them? SM Crivelli, C Giovagnoni, L Visseren, AL Scheithauer, N de Wit, ... Advanced drug delivery reviews 159, 214-231, 2020 | 77 | 2020 |
| Titin antibodies in “seronegative” myasthenia gravis—a new role for an old antigen C Stergiou, K Lazaridis, V Zouvelou, J Tzartos, R Mantegazza, C Antozzi, ... Journal of neuroimmunology 292, 108-115, 2016 | 77 | 2016 |
Jos PrickaertsPeitho Translationalpeithotranslational.com üzerinde doğrulanmış e-posta adresine sahip